Cancer Genomics

Overview

Conference Overview

This conference will provide an opportunity to learn about and keep up to date with the rapidly progressing area of cancer genomics. It will cover presentations from cancer genome projects, the areas of cancer functional genomics, systems biology, cancer immunogenomics and epigenomics, cancer mouse models and the translation and clinical impact of scientific results obtained. The meeting will bring together leading scientists from across these areas for a unique opportunity to interact and stimulate further integration of these efforts.

European cancer genomics research is particularly strong in the Heidelberg area, with three International Cancer Genome Consortium (www.icgc.org) projects being currently pursued with significant participation from Heidelberg institutions, including EMBL. As in our 2017 meeting, a large number of renowned speakers will be invited, with a strong representation of overseas speakers. The atmosphere at the conference will make this an exceptional event with cutting edge science, extensive scientific discussions and ample possibilities for meetings between and after sessions to facilitate in-depth discussions and new collaborations.

Session Topics

• Cancer genetics and mutation
• Drivers of cancer and genome-wide functional screens
• Cancer genome and epigenome
• Cancer and microenvironment: immunogenomics and single cells
• Cancer genome medicine

Speakers

Keynote Speakers

Stefan M. Pfister

Hopp Children’s Cancer Center Heidelberg (KiTZ)

Germany

Nikhil Wagle

Dana-Farber Cancer Institute

USA

Speakers

Michael F. Berger

Memorial Sloan Kettering Cancer Center

USA

Jesse S. Boehm

Broad Institute

USA

Angela Brooks

University of California, Santa Cruz

USA

Elías Campo

Hospital Clinic of the University of Barcelona August Pi i Sunyer Biomedical Research Institute (IDIBAPS)

Spain

Julie George

University of Cologne

Germany

Sean Grimmond

The University of Melbourne

Australia

Inigo Martincorena

Wellcome Trust Sanger Institute

UK

Elli Papaemmanuil

Memorial Sloan Kettering Cancer Center

USA

Peter J.M. Valk

Erasmus University Medical Center

The Netherlands

Catherine J. Wu

Dana-Farber Cancer Institute

USA

Scientific Organisers

Peter Campbell

Wellcome Trust Sanger Institute

UK

Jan Korbel

EMBL Heidelberg

Germany

Núria López-Bigas

ICREA, Institute for Research in Biomedicine

Spain

Matthew L. Meyerson

Dana-Farber Cancer Institute

USA

Conference Organisers

Tim Nürnberger

EMBL Heidelberg

Germany

Programme